» Articles » PMID: 22008910

Mesenchymal Stem/stromal Cells (MSCs): Role As Guardians of Inflammation

Overview
Journal Mol Ther
Publisher Cell Press
Date 2011 Oct 20
PMID 22008910
Citations 410
Authors
Affiliations
Soon will be listed here.
Abstract

Recent observations have demonstrated that one of the functions of mesenchymal stem/stromal cells (MSCs) is to serve as guardians against excessive inflammatory responses. One mode of action of the cells is that they are activated to express the interleukin (IL)-1 receptor antagonist. A second mode of action is to create a negative feedback loop in which tumor necrosis factor-α (TNF-α) and other proinflammatory cytokines from resident macrophages activate MSCs to secrete the multifunctional anti-inflammatory protein TNF-α stimulated gene/protein 6 (TSG-6). The TSG-6 then reduces nuclear factor-κB (NF-κB) signaling in the resident macrophages and thereby modulates the cascade of proinflammatory cytokines. A third mode of action is to create a second negative feedback loop whereby lipopolysaccharide, TNF-α, nitric oxide, and perhaps other damage-associated molecular patterns (DAMPs) from injured tissues and macrophages activate MSCs to secrete prostaglandin E(2) (PGE(2)). The PGE(2) converts macrophages to the phenotype that secretes IL-10. There are also suggestions that MSCs may produce anti-inflammatory effects through additional modes of action including activation to express the antireactive oxygen species protein stanniocalcin-1.

Citing Articles

Sepsis: the evolution of molecular pathogenesis concepts and clinical management.

Feng Z, Wang L, Yang J, Li T, Liao X, Kang Y MedComm (2020). 2025; 6(3):e70109.

PMID: 39991626 PMC: 11847631. DOI: 10.1002/mco2.70109.


Stem cell-derived exosome delivery systems for treating atherosclerosis: The new frontier of stem cell therapy.

Tariq H, Bukhari S, An R, Dong J, Ihsan A, Younis M Mater Today Bio. 2025; 30:101440.

PMID: 39866781 PMC: 11758955. DOI: 10.1016/j.mtbio.2024.101440.


Mesenchymal Stem Cells and Their Extracellular Vesicles: Therapeutic Mechanisms for Blood-Spinal Cord Barrier Repair Following Spinal Cord Injury.

Nakazaki M, Yokoyama T, Lankford K, Hirota R, Kocsis J, Honmou O Int J Mol Sci. 2025; 25(24.

PMID: 39769223 PMC: 11677717. DOI: 10.3390/ijms252413460.


ShK-modified UCMSCs Inhibit M1-Like Macrophage Polarization and Alleviate Osteoarthritis Progression via PI3K/Akt Axis.

Wu W, An X, Gong W, Yang L, Liu N, Liu B Adv Sci (Weinh). 2024; 12(9):e2406822.

PMID: 39721037 PMC: 11884619. DOI: 10.1002/advs.202406822.


Understanding dental pulp inflammation: from signaling to structure.

Pohl S, Akamp T, Smeda M, Uderhardt S, Besold D, Krastl G Front Immunol. 2024; 15:1474466.

PMID: 39534600 PMC: 11554472. DOI: 10.3389/fimmu.2024.1474466.


References
1.
Soehnlein O, Lindbom L . Phagocyte partnership during the onset and resolution of inflammation. Nat Rev Immunol. 2010; 10(6):427-39. DOI: 10.1038/nri2779. View

2.
Maggini J, Mirkin G, Bognanni I, Holmberg J, Piazzon I, Nepomnaschy I . Mouse bone marrow-derived mesenchymal stromal cells turn activated macrophages into a regulatory-like profile. PLoS One. 2010; 5(2):e9252. PMC: 2821929. DOI: 10.1371/journal.pone.0009252. View

3.
Tolar J, Villeneuve P, Keating A . Mesenchymal stromal cells for graft-versus-host disease. Hum Gene Ther. 2011; 22(3):257-62. DOI: 10.1089/hum.2011.1104. View

4.
Singer N, Caplan A . Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol. 2010; 6:457-78. DOI: 10.1146/annurev-pathol-011110-130230. View

5.
Wan Y . Regulatory T cells: immune suppression and beyond. Cell Mol Immunol. 2010; 7(3):204-10. PMC: 2868372. DOI: 10.1038/cmi.2010.20. View